Prothena Corp Public (PRTA) Revenue Growth (3y) (2015 - 2026)
Prothena Corp Public (PRTA) Revenue Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prothena Corp Public | 471.02 Mn | 141.56 Mn | - | 186.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.64% |
| Dec 31, 2025 | -92.51% |
| Sep 30, 2025 | 16.76% |
| Jun 30, 2025 | 49.91% |
| Mar 31, 2025 | 34.86% |
| Dec 31, 2024 | 21.90% |
| Sep 30, 2024 | -80.90% |
| Jun 30, 2024 | 30.01% |
| Mar 31, 2024 | -32.14% |
| Dec 31, 2023 | -4.25% |
| Sep 30, 2023 | 714.60% |
| Jun 30, 2023 | 174.17% |
| Mar 31, 2023 | 148.70% |
| Dec 31, 2022 | 479.90% |
| Sep 30, 2022 | 94.87% |
| Jun 30, 2022 | 98.80% |
| Mar 31, 2022 | 83.70% |
| Dec 31, 2021 | 82.13% |
| Sep 30, 2021 | 717.22% |
| Jun 30, 2021 | 499.36% |